These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23460187)

  • 1. Recurarization after sugammadex following a prolonged rocuronium infusion for induced hypothermia.
    Murata T; Kubodera T; Ohbayashi M; Murase K; Adachi YU; Matsuda N
    Can J Anaesth; 2013 May; 60(5):508-9. PubMed ID: 23460187
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of rocuronium and sugammadex in a patient with myasthenia.
    Petrun AM; Mekis D; Kamenik M
    Eur J Anaesthesiol; 2010 Oct; 27(10):917-8. PubMed ID: 20375901
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rocuronium-sugammadex complex in the reversal of neuromuscular blockade after implantation of an endobronchial stent following lung transplant].
    Brito Jiménez LG; Soto Machín L
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):621-2. PubMed ID: 22263411
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.
    Blobner M; Eriksson LI; Scholz J; Motsch J; Della Rocca G; Prins ME
    Eur J Anaesthesiol; 2010 Oct; 27(10):874-81. PubMed ID: 20683334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rocuronium used in rapid sequence intubation and reversal with sugammadex in a patient with myasthenia gravis].
    Illodo Miramontes G; Doniz Campos M; Filgueira Garrido P; Vázquez Martínez A
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):626-7. PubMed ID: 22263415
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of moderate and intense neuromuscular block induced by rocuronium with low doses of sugammadex for intraoperative facial nerve monitoring.
    Fabregat López J; Porta Vila G; Martin-Flores M
    Rev Esp Anestesiol Reanim; 2013 Oct; 60(8):465-8. PubMed ID: 23664256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of sugammadex in a patient with myotonic dystrophy.
    Matsuki Y; Hirose M; Tabata M; Nobukawa Y; Shigemi K
    Eur J Anaesthesiol; 2011 Feb; 28(2):145-6. PubMed ID: 20962659
    [No Abstract]   [Full Text] [Related]  

  • 9. Sugammadex-rocuronium dosing.
    Kopman AF
    Anesth Analg; 2007 Sep; 105(3):883-4; author reply 884. PubMed ID: 17717263
    [No Abstract]   [Full Text] [Related]  

  • 10. Rocuronium and sugammadex in a 3 days old neonate for draining an ovarian cyst. Neuromuscular management and review of the literature.
    Carlos RV; Torres ML; de Boer HD
    Braz J Anesthesiol; 2016; 66(4):430-2. PubMed ID: 27343797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rocuronium used after sugammadex].
    García Sánchez JI; Martínez Hurtado ED; Tordecilla Echenique YY; Santa-Ursula TJ
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):620-1. PubMed ID: 22263410
    [No Abstract]   [Full Text] [Related]  

  • 12. Sugammadex in anesthesia practice.
    Duvaldestin P; Plaud B
    Expert Opin Pharmacother; 2010 Nov; 11(16):2759-71. PubMed ID: 20977408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rocuronium and sugammadex in myotonic dystrophy.
    Baumgartner P
    Anaesth Intensive Care; 2010 Sep; 38(5):959-60. PubMed ID: 20865895
    [No Abstract]   [Full Text] [Related]  

  • 14. Sugammadex reversal of rocuronium-induced neuromuscular blockade in two types of neuromuscular disorders: Myotonic dystrophy and spinal muscular atrophy.
    Stewart PA; Phillips S; De Boer HD
    Rev Esp Anestesiol Reanim; 2013 Apr; 60(4):226-9. PubMed ID: 22947194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reasoning of an anomaly: residual block after sugammadex.
    Naguib M; Brull SJ; Arkes HR
    Anesth Analg; 2013 Aug; 117(2):297-300. PubMed ID: 23881373
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sugammadex and profound rocuronium neuromuscular blockade induced by magnesium sulphate].
    Grandjean B; Guerci P; F Vial ; Raft J; Fuchs-Buder T; Bouaziz H
    Ann Fr Anesth Reanim; 2013 May; 32(5):378-9. PubMed ID: 23664923
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of rocuronium-induced anaphylactic shock, improved by sugammadex].
    Badaoui R; Popov I; Dupont H
    Can J Anaesth; 2012 Sep; 59(9):909-10. PubMed ID: 22653841
    [No Abstract]   [Full Text] [Related]  

  • 18. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report.
    Kawano T; Tamura T; Hamaguchi M; Yatabe T; Yamashita K; Yokoyama M
    J Clin Anesth; 2012 Feb; 24(1):62-4. PubMed ID: 22154092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose rocuronium for rapid-sequence induction and reversal with sugammadex in two myasthenic patients.
    Casarotti P; Mendola C; Cammarota G; Della Corte F
    Acta Anaesthesiol Scand; 2014 Oct; 58(9):1154-8. PubMed ID: 25182127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.